9/15- Interstitial Lung Disease Flashcards

1
Q

What are the components of the pulmonary interstitium?

A
  • Alveolar epithelium
  • Pulmonary capillary endothelium
  • Basement membrane
  • Perivascular and perilymphatic tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does ILD refer to?

A

Interstitial Lung Diseases

  • Diffuse Parenchymal Lung Disorders
  • Heterogeneous group of disorders grouped together due to similar clinical, physiologic, radiographic, and pathologic features

May be classified by:

  • Known causes or unknown causes
  • Based on histo-pathology: alveolitis/fibrosis or granulomatous or alveolar filling
  • Based on onset: acute or chronic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Flowchart classification of diffuse parenchymal lung disease

A
  • Known cause (drugs, collagen vascular dz…) - Idiopathic interstitial pneumonia
  • Idiopathic pulmonary fibrosis
  • IIP other than idiopathic pulmonary fibrosis (different pneumonias)
  • Granulomatus DPLD (sarcoidosis)
  • Other forms of DPLD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnostic approach to ILD diagnosis?

A

Multidisciplinary Clinical + Radiology + Pathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Typical presentation of ILD

  • Age
  • Gender
  • Symptoms
A
  • Typ > 50 yo
  • Mostly women > men EXCEPT rheumatoid arthritis and IPF

Symptoms:

  • Progressive dyspnea
  • Dry cough
  • Occ. weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some ILDs with acute onset (days-weeks)?

A
  • AIP (Hamman-Rich Syndrome)
  • Acute pneumonitis from collagen vascular disease (especially SLE)
  • Cryptogenic organizing pneumonia
  • Drugs
  • Diffuse alveolar hemorrhage
  • Eosinophilic lung disease
  • Hypersensitivity pneumonitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are some ILDs with subacute onset (weeks - months)?

A
  • Collagen vascular disease-associated ILD
  • Cryptogenic organizing pneumonia
  • Drugs
  • Subacute hypersensitivity pneumonitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some ILDs with chronic onset (months - years)?

A
  • IPF, NSIP, and other IIPs
  • Pneumoconioses (lung disorders caused by occpational disorders)
  • Chronic hypersensitivity pneumonitis
  • Collagen vascular disease-associated ILD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What illness are associated with ILDs that you might expect to find in past medical history?

A
  • Collagen vascular disorders
  • Rheumatoid arthritis
  • SLE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What diseases might be expected in family history for someone with ILD?

A
  • Sarcoidosis
  • Interstitial pulmonary fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What medication history might you find for someone with ILD?

A

MANY

  • Methotrexate
  • Amiodarone
  • Also some illicit drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What might you look for in the social history of someone with ILD?

A
  • Occupation: ship-building (demolition– asbestos), insulator, sand-blasting (silica exposure), farming
  • Smoking history: IPF, RB-ILD, DIP

(RB-ILD so associated that it may get better upon smoking cessation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What might be expected in the physical exam for someone with ILD?

A

Most findings from auscultation

  • Tachypnea
  • Rales (“Velcro” crackles)*
  • Clubbing
  • Exercise desaturation

Late stages:

  • Signs of right heart failure
  • Cyanosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What labs might you find for someone with ILD?

  • ABG
  • Certain disease disorder labs
  • Others
A

ABG

  • Early stages: no changes
  • Late stages: hypoxemia; elevated A-a gradient

Connective tissue disorder labs:

  • ANA
  • Rheumatoid factor

Others:

  • ACE and Ca elevated in Sarcoidosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe pulmonary function tests for patients with ILD?

  • FEV1/FVC
  • TLC
  • DLCO
A

Restrictive pattern

  • Decreased lung volumes; TLC reduction determines severity of disease
  • Normal FEV1/FVC

Reduced DLCO (diffusion capacity) secondary to physiological alveolar-capillary block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F: PFT can help determine specific disease/etiology of ILD?

A

False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the radiologic patterns of ILD?

A
  • Reticular: fine lines due to thickening and fibrosis of interstitium
  • Nodular
  • Reticulo-nodular
  • Ground glass: hazy; can see through it, but somewhat obscure (more in acute-onset ILDs)
  • Alveolar
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What conditions fall into the following radiologic patterns of ILD:

  • Reticular
  • Nodular
  • Reticulo-nodular
  • Ground glass
  • Alveolar
A

Reticular

  • IPF (idiopathic pulmonary fibrosis)
  • Asbestosis
  • Connective-tissue associated

Nodular

  • Sarcoidosis
  • Silicosis
  • Hypersensitivity
  • Pneumonitis

Reticulo-nodular

Ground glass

  • NSIP (nonspecific interstitial pneumonia)
  • DIP (desquamative interstitial pneumonia)
  • RBILD (respiratory bronchiolitis interstitial lung dz)
  • Pulmonary hemorrhage

Alveolar

  • Cryptogenic organizing pneumonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which ILDs are predominantly in the upper lobe? Lower lobe?

A

Upper lobe

  • Sarcoidosis
  • Silicosis
  • Acute
  • Hypersensitivity pneumonitis (HP)
  • Ankylosing spondylosis

Lower lobes:

  • IPF
  • Chronic HP
  • Asbestosis
20
Q

Pneumothorax hints at which ILD?

A

Lymphangioleiomyomatosis (LAM)

21
Q

Pleural plaques hints at which ILD?

A

Asbestosis

  • Asbestos fibers can go down all the way to pleura and cause irritation -> thickening of pleura (doesn’t progress to cancer, but is a marker of exposure)
22
Q

Hilar adenopathy hints at which ILD?

A

Sarcoidosis

23
Q

What is seen here?

A

Reticular pattern, lower lobe predominant

  • Increased “haziness”, esp at base
  • Very fine lines

This could be:

  • IPF
  • CT-disease related
  • Asbestosis
24
Q

What imaging is used to evaluate ILD?

A

High resolution CT; superior to CXR

  • Extent and distribution of disease
  • Patterns
25
What are some pathologic diagnostic tests?
Bronchoscopy - Bronchoalveolar lavage - Transbronchial lung biopsy Surgical lung biopsy Other biopsy: - Skin: sarcoid
26
What are the pathologic categories and ILDs within them (that we will cover specifically)?
**Alveolitis/Fibrotic** - IPF - NSIP - CT disease related - Pneumoconiosis **Granulomatous** - Sarcoidosis - Hypersensitivity pneumonitis **Alveolar filling** - COP (cryptogenic organizing pneumonia)
27
Characteristics of **Idiopathic Pulmonary Fibrosis (IPF)** - Age of onset - Gender bias - Onset - PE findings - Pathology - Imaging
- Age of onset **6th-7th decade** (rare under 50 yo) - **Men** \> women - Chronic onset - PE: **velcro rales and clubbing** - Pathology: **usual interstitial pneumonia** _Imaging:_ - **Reticular** infiltrates - Lower lobe predominant - Subpleural with **honeycombing** in late stages (pockets of scared-down lung) - Temporal heterogeneity
28
What is seen here?
IPF findings/reticular pattern Arrows point to honeycombing (burnt out lung)
29
Treatment for IPF?
_Best **supportive care**_ - O2 therapy - Pulmonary rehab - Early recognition of terminal decline and liaison with health care specialists **Lung transplantation** only option for some: - DLCO under 40% predicted or progressive (\>10% decline in FVC) - Refer early - Single or double Most pts die on transplant list (typ life expectancy = 5yrs?) _Medications (conditional recommendation):_ **- Nintedanib** (TK inhib with multiple targets, including VEGF, FGF, and PDGF receptors) **- Pirfernidone** (oral antifibrotic with pleiotropic effects: regulate important profibrotic/proinflammatory cyotkine cascades while reducing fibroblast proliferation and collagen synthesis) **- Anti-acid therapy** (reflux/GERD may contribute to chronic lung inflammation and resultant IPF)
30
What treatments are strongly NOT recommended in IPF? What about conditionally not recommended?
- Anticoagulation (warfarin) - Imatinib (selective TK inhibitor against PDGF) - Combo prednisone, azathioprine, and N-acetylcysteine - Selective endothelin receptor antagonist (ambrisentan) (No steroids! Although these are common treatment for some other ILDs) _Conditionally not recommended:_ - PDE5 inhibitor (sildenafil) - Dual endothelin receptor antagonists (macitentan, bosentan) - N-acetyl monotherapy
31
**T/F:** Honeycomb lung is specific for IPF?
False - Sign of "burnt out lung"; any end-stage ILD - At this point, lung transplant is really your only hope
32
Characteristics of **NSIP**? - Commonality - Age - Epidemiology - History - PE findings - Pathology - Imaging - Diagnosis
- **2nd most common** diagnosis - **Middle aged** - Majority are **smokers** - Similar hx to IFP - Similar PE to IFP, but less clubbing - Pathology: **homogeneous** interstitial thickening - Imaging: **diffuse ground glass infiltrates** - **Surgical biopsy** required to make diagnosis
33
How do connective tissue disease related ILDs differ from IPF?
- Part of multisystem disease, usually apparent prior to pulmonary involvement - Pleural involvement common
34
What CT diseases most common involve pulmonary manifestations in CT disease related ILDs?
- SLE - Rheumatoid arthritis
35
What does pulmonary involvement in SLE look like?
- Pleuritis/pleural effusion (most common) - Alveolar hemorrhage - Acute pneumonitis - ILD (0-4%) - Diaphragmatic weakness
36
What does pulmonary involvement in rheumatoid arthritis?
_2 unique issues:_ **1.** **Joint disease** usually precedes pulmonary involvement **2.** **Males** \> females Pulmonary complications are rare - Pleural effusion is most common (under 5%) _Also:_ - Fibrosing alveolitis/Fibrosis - Necrobiotic nodules - Pleural effusion - Bronchiolitis obliterans - ILD due to drug therapies (e.g. methotrexate)
37
Characteristics of asbestos associated lung disease - Exposure - Upper or lower lung fields - Benign vs. malignant - Natural history - Symptoms - Radiology - Complications
**- Exposure:** shipyard workers (WWII), refineries, demolition of old buildings, construction ,insulation, bake repair **- Asbestosis** (pulmonary fibrosis)- more in lower lung fields **- Benign asbestosis**- related pleural disease (pleural plaques/adhesions) **- Bronchogenic cancer** **- Mesothelioma:** pleural malignancy (not associated with smoking at all) **- Natural hx:** insidious onset; many years after exposure (usually \> 20 yrs!) **- Sx:** insidious onset of dyspnea and cough _Radiology_ - Irregular opacities primarily in lower lobes - May be associated with pleural plaques/thickening _Complications:_ - Acts as co-carcinogen with tobacco smoke - Up to 50x increase in lung cancer among asbestos workers who smoke compared to smokers in other trades
38
What is this?
Asbsestosis
39
Characteristics of **Silicosis**? - Overall - Work environment - Natural history - Radiographic features - Diagnosis - Complications
Chronic, fibronodular lung disease caused by long term exposure to crystalline silica **- Work environment:** stone cutting/polishing, mining, foundry work, sandblastin - Usually requires exposure of \> 5 yrs **- Natural hx:** variable; most commonly slowly progressive dyspnea, cough, sputum _Radiographically:_ - Upper lobe (apex) - Hilar adenopathy (egshell calcifications) _Diagnosis:_ - CXR and history - Occasionally need lung biopsy - High resolution CT may be helpful _Complications:_ - Increased risk for TB (5-43%) - No increased risk for lung cancer (?)
40
Characteristics of Sarcoidosis: - Gender - Epidemiology - Clinical presentation - Symptoms - Radiologic changes
- Multisystem disease of unknown etiology - **Females** \> males - **Black** \> white - Usually **under 40** **Clinical presentation**: multi-system disease which may present acutely, subacutely, or chronically - CNS, eye, skin, bone, cardiac, endocrine - Most commonly pts are asymptomatic with an abnormal CXR _Radiologic stages_ **0:** no CXR anbormality (5-10%, ie sarcoid diagnosed in another organ system) **I:** LN enlargement without parenchymal change, most common\* **II:** nodes +, diffuse parenchymal changes **III:** nodes -, diffuse chagnes IV: evidence of fibrosis
41
Diagnosis of sarcoidosis?
- Rests on clinical assessment and compatible tissue biopsy - Hallmark pathology is non-caseating granuloma - Rule out other disorders, esp TB - Tissue diagnosis: transbronchial biopsy + ve in 50-60% with normal CXR; 85-90% with abnormal CXR
42
Treatment of Sarcoidosis? - Natural history - When to treat - Treat with what
_Course:_ - 30-50% spontaneously remit in 3 yr period - 20-30% remain stable - 30% progressive Treat if **symptomatic** or **vital organ involvement** Treat with **immunosuppression**
43
Characteristics of Hypersensitivity Pneumonitis - Exposure - Radiology - Diagnosis - Pathology
_Exposure_ - From inhalation of and sensitivity to organic dusts - Antigens are quite varied but clinical response to all is similar - Most common is after exposure to thermophilic actinomyces in moldy hay, silos etc. (Farmer's lung) _Radiology_ - Diffuse, small nodules that appears as ground glass infiltrates - Acute upper lobe and chronic lower lobe **Diagnosis:** requires a high index of suspicion **Pathology:** Peribronchial lymphocytic infiltrates with poorly formed granulomas
44
Treatment for Hypersensitivity Pneumonitis?
- Avoidance of causative antigenic agent - Corticosteroids may have role in treating severe or progressive disease
45
Characteristics of COP (Cryptogenic Organizing Pneumonia) - Epidemiology - Symptoms - CXR features - HRCT - Pathology - Prognosis - Treatment
Idiopathic "BOOP": bronchiolitis obliterans organizing pneumonia - Unknown etiology **Epidemiology:** 5th-6th decades (equal genders) **Symptoms:** - Malaise - Weight loss - Mylagias - Cough - SOB - Typically following respiratory infection **CXR:** patchy or diffuse infiltrates - Often recurrent or migratory **HRCT:** airspace around ground glass opacities and bronchial wall thickening/dilation **Pathology:** patchy cellular airspace fibrosis in alveoli and alveolar ducts **Prognosis:** good; spontaneous remission in 50% **Treatment:** steroids; very sensitive
46
Summary